Nestlé Developing Microbiome-Based Supplements with Dutch Partner

Nestlé Health Science is putting its financial weight behind the Netherlands' Caelus Health to help commercialize microbiome-based food supplements for early intervention in a number of diseases.

Bacteria cells
• Source: Shutterstock

Nestle Health Science SA has entered into a strategic collaboration with Netherlands-based Caelus Health to develop microbiome-based food supplements for the prevention and early treatment of cardio-metabolic diseases.

Under the terms of a global development and option agreement signed by both firms, Nestlé has agreed to fund Caelus’...

More from Innovation & IP

EU Industry Wants EFSA Changes To Support Innovation

 
• By 

Prominent trade groups call on the European Commission to improve risk assessment of innovative food products by making changes to processes at the European Food Safety Authority.

AESGP Annual Meeting: European OTC Market Outlook ‘Very Positive’ Thanks To Prevention Trend

 
• By 

The European OTC market grew at double the rate of the global market in the last twelve months, according to IQVIA Consumer Health, driven by a long-term trend for prevention. Consultancy Simon Kucher identifies a desire to live a longer, healthier life as the primary concern behind this trend.

OTC Marketing Awards 2025 Open For Entries

 
• By 

Find out how to enter the OTC Marketing Awards before the 1 September entry deadline.

Haleon Utilizing AI To Develop Natural CHC Products

 
• By 

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

More from Wellness

AESGP Annual Meeting: European OTC Market Outlook ‘Very Positive’ Thanks To Prevention Trend

 
• By 

The European OTC market grew at double the rate of the global market in the last twelve months, according to IQVIA Consumer Health, driven by a long-term trend for prevention. Consultancy Simon Kucher identifies a desire to live a longer, healthier life as the primary concern behind this trend.

Price To Resolve US Hemp Dilemma Too High In House Appropriators’ FY 2026 FDA Spending Bill

 

Provisions in bill approved by Agriculture, Rural Development, FDA and Related Agencies Subcommittee aren’t likely to pass largely because they set a price too high for delta-8 THC and other ingredients to meet the definition of hemp as a de-scheduled substance.

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By 

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.